The gastric precancerous cascade

Invasive gastric carcinoma is preceded by a cascade of precancerous lesions. The first recognized histologic change is active chronic inflammation, which may persist as such: non‐atrophic chronic gastritis (no gland loss), or advance to multifocal atrophic gastritis (MAG), the first real step in the precancerous cascade. The following steps are: intestinal metaplasia (first “complete” and then “incomplete”); dysplasia, first low grade and then high grade (equivalent to “carcinoma in situ”). The following step is invasive carcinoma, which is thought to be associated with degradation of the intercellular matrix.

[1]  M. Borodovsky,et al.  cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Alter Mj,et al.  Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. , 1991, BMJ.

[3]  N. Yoshimura,et al.  Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels , 2009, International journal of cancer.

[4]  B. Nielsen,et al.  Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high‐ and low‐risk countries , 2010, International journal of cancer.

[5]  K. Miki Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels — “ABC method” , 2011, Proceedings of the Japan Academy. Series B, Physical and biological sciences.

[6]  L. Bravo,et al.  Eosinophils and mast cells in chronic gastritis: possible implications in carcinogenesis. , 2008, Human pathology.

[7]  E. Fontham,et al.  Age at Acquisition of Helicobacter pylori Infection: Comparison of Two Areas with Contrasting Risk of Gastric Cancer , 2004, Helicobacter.

[8]  M. Blaser,et al.  Helicobacter pylori in health and disease. , 2009, Gastroenterology.

[9]  S. Czinn,et al.  Helicobacter-associated gastritis in SCID mice , 1995, Infection and immunity.

[10]  P. Correa,et al.  Gastric cancer in Colombia. III. Natural history of precursor lesions. , 1976, Journal of the National Cancer Institute.

[11]  M. Gail,et al.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2000, Journal of the National Cancer Institute.

[12]  A. Gobert,et al.  BASIC AND TRANSLATIONAL — ALIMENTARY TRACT Spermine Oxidase Mediates the Gastric Cancer Risk Associated With Helicobacter pylori CagA , 2011 .

[13]  B. Morson Carcinoma Arising from Areas of Intestinal Metaplasia in the Gastric Mucosa , 1955, British Journal of Cancer.

[14]  R. Peek,et al.  Helicobacter pylori in gastric carcinogenesis: mechanisms. , 2013, Gastroenterology clinics of North America.

[15]  M. Plummer,et al.  Helicobacter pylori cytotoxin-associated genotype and gastric precancerous lesions. , 2007, Journal of the National Cancer Institute.

[16]  S. Tominaga,et al.  A Prospective Study of Atrophic Gastritis and Stomach Cancer Risk , 1992, Japanese journal of cancer research : Gann.

[17]  E. Kuipers,et al.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. , 2010, Gastrointestinal endoscopy.

[18]  M. Blaser,et al.  Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. , 1991, The New England journal of medicine.

[19]  L. Janzon,et al.  Positive correlation between H,K-adenosine triphosphatase autoantibodies and Helicobacter pylori antibodies in patients with pernicious anemia. , 1994, Scandinavian journal of gastroenterology.

[20]  T. Blanchard,et al.  Immunological determinants that may affect the Heliobacter pylori cancer risk , 1998 .

[21]  T. Graham,et al.  The clonal origins of dysplasia from intestinal metaplasia in the human stomach. , 2011, Gastroenterology.

[22]  M. Ghigna,et al.  Type or extension of intestinal metaplasia and immature/atypical "indefinite-for-dysplasia" lesions as predictors of gastric neoplasia. , 2006, Human pathology.

[23]  J. Gisbert,et al.  Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence , 2013, International journal of cancer.

[24]  G. Friedman,et al.  Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. , 1997, Gut.

[25]  D. Graham,et al.  Eradication of gastric cancer is now both possible and practical. , 2013, Seminars in cancer biology.

[26]  P. Correa The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. , 1980, Frontiers of gastrointestinal research.

[27]  T. Shimosegawa,et al.  Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach. , 2009, World journal of gastroenterology.

[28]  M. Achtman,et al.  Recombination and clonal groupings within Helicobacter pylori from different geographical regions , 2012 .

[29]  E. Fontham,et al.  Gastric precancerous process in a high risk population: cross-sectional studies. , 1990, Cancer research.

[30]  P. Correa,et al.  The transmission of Helicobacter pylori. A critical review of the evidence. , 1995, International journal of epidemiology.

[31]  Laura C. Greaves,et al.  Mechanisms of field cancerization in the human stomach: the expansion and spread of mutated gastric stem cells. , 2008, Gastroenterology.

[32]  J. Goldenring,et al.  Current understanding of SPEM and its standing in the preneoplastic process , 2009, Gastric Cancer.

[33]  N. Muñoz,et al.  Age and Severity of Mucosal Lesions Influence the Performance of Serologic Markers in Helicobacter pylori–Associated Gastroduodenal Pathologies , 2008, Cancer Epidemiology Biomarkers & Prevention.

[34]  P. Correa,et al.  Carcinoma and intestinal metaplasia of the stomach in Colombian migrants. , 1970, Journal of the National Cancer Institute.

[35]  J. Posthuma,et al.  Morphology of the Stomach and Gastric Secretion in Malays and Chinese and the Different Incidence of Gastric Ulcer and Cancer in These Races , 1938 .

[36]  L. Bravo,et al.  Virulence-associated genotypes of helicobacter pylori: do they explain the african enigma? , 2002, American Journal of Gastroenterology.

[37]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[38]  G. Capellá,et al.  Gastric cancer occurrence in preneoplastic lesions: A long‐term follow‐up in a high‐risk area in Spain , 2010, International journal of cancer.

[39]  J. Mills,et al.  Mature chief cells are cryptic progenitors for metaplasia in the stomach. , 2010, Gastroenterology.

[40]  P. Sipponen,et al.  INTESTINAL METAPLASIA WITH COLONIC‐TYPE SULPHOMUCINS IN THE GASTRIC MUCOSA; ITS ASSOCIATION WITH GASTRIC CARCINOMA , 1980, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[41]  L. Bravo,et al.  Analysis of cagA in Helicobacter pylori Strains from Colombian Populations with Contrasting Gastric Cancer Risk Reveals a Biomarker for Disease Severity , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[42]  E. Kuipers,et al.  Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. , 2008, Gastroenterology.

[43]  D. Graham,et al.  Adherence of Helicobacter pylori to areas of incomplete intestinal metaplasia in the gastric mucosa. , 1996, Gastroenterology.

[44]  P. Malfertheiner,et al.  OLGA staging for gastritis: a tutorial. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[45]  E. Fontham,et al.  Diet and chronic atrophic gastritis: a case-control study. , 1986, Journal of the National Cancer Institute.

[46]  M. Plummer,et al.  International agency for research on cancer. , 2020, Archives of pathology.

[47]  G. Stemmermann,et al.  Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. , 1968, Journal of the National Cancer Institute.

[48]  T G Blanchard,et al.  Review article: Immunological determinants that may affect the Helicobacter pylori cancer risk. , 1998, Alimentary pharmacology & therapeutics.

[49]  R. Rappuoli,et al.  Helicobacter pylori virulence and genetic geography. , 1999, Science.

[50]  F. Chan,et al.  Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication , 2004, Gut.

[51]  P. Barbini,et al.  Gastric intestinal metaplasia type III cases are classified as low‐grade dysplasia on the basis of morphometry , 1993, The Journal of pathology.

[52]  P. Malfertheiner,et al.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) , 2012, Endoscopy.

[53]  K. Miki Gastric cancer screening using the serum pepsinogen test method , 2002, Gastric Cancer.

[54]  J. DeLany,et al.  Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. , 1996, American journal of epidemiology.

[55]  L. Bravo,et al.  Intestinal Helminthiasis in Colombian Children Promotes a Th2 Response to Helicobacter pylori: Possible Implications for Gastric Carcinogenesis , 2005, Cancer Epidemiology Biomarkers & Prevention.

[56]  M. Blaser,et al.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.

[57]  L. Bravo,et al.  Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk , 2011, Gut.

[58]  P. Correa,et al.  Sulphomucins favour adhesion of Helicobacter pylori to metaplastic gastric mucosa. , 1999, Journal of clinical pathology.

[59]  Ming-Shiang Wu,et al.  Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. , 2009, Gastroenterology.

[60]  M. Piazuelo,et al.  Pathology of Gastric Intestinal Metaplasia: Clinical Implications , 2010, The American Journal of Gastroenterology.

[61]  Khean Lee Goh,et al.  Screening for gastric cancer in Asia: current evidence and practice. , 2008, The Lancet. Oncology.

[62]  T. Rokkas,et al.  Detection of an increased incidence of early gastric cancer in patients with intestinal metaplasia type III who are closely followed up. , 1991, Gut.

[63]  E. Fontham,et al.  Long term follow up of patients treated for Helicobacter pylori infection , 2005, Gut.

[64]  M. Blaser,et al.  Role of Helicobacter pylori cagA+ strains and specific host immune responses on the development of premalignant and malignant lesions in the gastric cardia , 1999, International journal of cancer.

[65]  P. Laurén,et al.  On the role of heterotopias of the intestinal epithelium in the pathogenesis of gastric cancer. , 2009, Acta pathologica et microbiologica Scandinavica.

[66]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[67]  N. Muñoz,et al.  Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia , 1994, International journal of cancer.

[68]  E. Kuipers,et al.  The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. , 2009, Gastrointestinal endoscopy.

[69]  M F Dixon,et al.  The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.

[70]  M. Sobrinho-Simões,et al.  Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. , 1999, Cancer research.

[71]  T. Hirota,et al.  Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. , 1980, Journal of the National Cancer Institute.

[72]  M. Rugge,et al.  Gastric dysplasia: the Padova international classification. , 2000, The American journal of surgical pathology.

[73]  M. Filipe,et al.  Intestinal metaplasia and its variants in the gastric mucosa of Portuguese subjects: a comparative analysis of biopsy and gastrectomy material. , 1986, Human pathology.

[74]  B. Marshall,et al.  UNIDENTIFIED CURVED BACILLI IN THE STOMACH OF PATIENTS WITH GASTRITIS AND PEPTIC ULCERATION , 1984, The Lancet.

[75]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[76]  S. Leung,et al.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.

[77]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[78]  Keith T. Wilson,et al.  Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk , 2010, Clinical Microbiology Reviews.

[79]  M. Gail,et al.  Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2001, Journal of the National Cancer Institute.

[80]  R. P. Blankfield,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[81]  D. Graham,et al.  Topographic patterns of intestinal metaplasia and gastric cancer , 2000, American Journal of Gastroenterology.

[82]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[83]  H. Watanabe,et al.  Evaluation of gastric biopsies for neoplasia: differences between Japanese and Western pathologists. , 1999, The American journal of surgical pathology.

[84]  D. McGee,et al.  Gastric intestinal metaplasia in ethnic groups in the southwestern United States. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[85]  M. Rugge,et al.  Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. , 2011, Human pathology.

[86]  N. Yoshimura,et al.  Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer , 2004, International journal of cancer.

[87]  G. Friedman,et al.  Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.

[88]  P. Malfertheiner,et al.  Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) , 2012, Endoscopy.

[89]  R. Rappuoli,et al.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[90]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[91]  P. Correa,et al.  A human model of gastric carcinogenesis. , 1988, Cancer research.

[92]  E. Kuipers,et al.  Helicobacter pylori Eradication and Gastric Cancer: When Is the Horse Out of the Barn? , 2009, The American Journal of Gastroenterology.

[93]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[94]  J. Fraumeni,et al.  Cigarette smoking and other risk factors for progression of precancerous stomach lesions. , 1992, Journal of the National Cancer Institute.

[95]  Ali Ms Letter: Geriatrics is medicine. , 1974, Lancet.

[96]  A. Lilienfeld,et al.  MODEL FOR GASTRIC CANCER EPIDEMIOLOGY , 1976, The Lancet.

[97]  E. Kuipers,et al.  Precancerous lesions in the stomach: from biology to clinical patient management. , 2013, Best practice & research. Clinical gastroenterology.

[98]  G. Capellá,et al.  Helicobacter pylori cagA and vacA Genotypes as Predictors of Progression of Gastric Preneoplastic Lesions: A Long-Term Follow-Up in a High-Risk Area in Spain , 2011, The American Journal of Gastroenterology.

[99]  P. Correa,et al.  Morbidity and mortality from cancer in Cali, Colombia. , 1966, Journal of the National Cancer Institute.

[100]  J. Noto,et al.  The Helicobacter pylori cag Pathogenicity Island. , 2012, Methods in molecular biology.

[101]  B. C. Wong,et al.  Gastric cancer chemoprevention: the current evidence. , 2013, Gastroenterology clinics of North America.

[102]  E. Fontham,et al.  Gastric precancerous process in a high risk population: cohort follow-up. , 1990, Cancer research.

[103]  K. Chayama,et al.  Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5‐year prospective study of patients with atrophic gastritis , 2002, Alimentary pharmacology & therapeutics.

[104]  J. Rotter,et al.  Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. , 1982, Gastroenterology.